Strathspey Crown Holdings Group, LLC, 10% Owner at AEON Biopharma, Inc. (AEON), sold 7,380,394 shares at $10.00 ($73.8M) on 2023-08-11, disclosed to the SEC on 2023-08-14.
Open-market sale of $73.8M AEON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.